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Effect of a Novel Transition Program on Disability After Stroke
A Trial Protocol
Emily Somerville, OTD, OTR/L; Brittany Minor, MS, OTR/L; Marian Keglovits, MSci, OTD, OTR/L; Yan Yan, PhD; Susan Stark, PhD, OTR/L

Abstract
IMPORTANCE A gap in care for stroke survivors exists at the point of transition from inpatient
rehabilitation to home, when survivors encounter new environmental barriers because of the
cognitive and sensorimotor sequelae of stroke. Resolving these barriers and improving
independence in the community have the potential to significantly improve stroke survivors’ longterm morbidity.
OBJECTIVE To investigate the efficacy and safety of a novel enhanced rehabilitation transition
program to reduce environmental barriers and improve daily activity performance and community
participation among stroke survivors.

Key Points
Question Is a novel enhanced
rehabilitation transition program,
Community Participation Transition
After Stroke (COMPASS), more effective
at improving community participation
and daily activity performance and
reducing environmental barriers among
stroke survivors than an equivalent dose
of attentional control?
Findings In this phase 2b, single-blind,

DESIGN, SETTING, AND PARTICIPANTS This is a phase 2b, single-blind, parallel-group, randomized

parallel-group, randomized clinical trial,

clinical trial. Participants will be randomized using a 1:1 allocation ratio, stratified by Functional

180 adults who have had ischemic or

Independence Measure and age, to either attentional control or the intervention. Community

hemorrhagic strokes will be studied as

Participation Transition After Stroke (COMPASS) is a complex intervention that uses 2

they transition home from inpatient

complementary evidence-based interventions: home modifications and strategy training delivered

rehabilitation.

in the home. Community participation after stroke, measured by the Reintegration to Normal Living
Index, is the primary outcome. Secondary outcomes include quality of life after stroke, measured by
the Stroke Impact Scale, and daily activity performance and magnitude of environmental barriers in
the home, both measured by the In-Home Occupational Performance Evaluation. An intention-totreat analysis will be used. A total of 180 participants, who are 50 years or older, were independent in

Meaning Removing environmental
barriers faced by stroke survivors as they
transition home may improve daily
activity performance as well as home
and community participation.

activities of daily living prior to stroke, and are undergoing inpatient rehabilitation following stroke
with a plan to be discharged home, will be included in the study.
DISCUSSION Stroke is a leading cause of serious long-term disability in the United States. The
COMPASS study is ongoing. To date, 99 participants have been recruited and 77 randomized, with 37

+ Supplemental content
Author affiliations and article information are
listed at the end of this article.

in the treatment group and 40 in the control group. Resumption of previous activities immediately
after discharge can improve immediate and long-term community participation. Results from this
study will fill a critical gap in stroke rehabilitation evidence by providing important information about
the long-term community participation and daily activity performance among stroke survivors as
well as environmental barriers in their homes.
TRIAL REGISTRATION ClinicalTrials.gov identifier: NCT03485820
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Introduction
Stroke is highly prevalent, costly, and disabling. Stroke is a leading cause of long-term disability in the
United States.1 Half of stroke survivors are dependent on caregivers to perform their activities of
daily living (ADLs).2,3 Unless a solution is identified to improve the long-term outcome of stroke
survivors, annual costs attributed to stroke in the United States are projected to increase to $240.67
billion by 2030.
The transition from inpatient rehabilitation (IR) to home is an important window of opportunity
for intervention.4,5 Resumption of previous activities immediately after discharge,6 at a time when
people with stroke report struggling to reestablish daily routines,5 can improve immediate and longterm community reintegration. Providing environmental support improves performance of ADLs
but is unproven among stroke survivors. Strategy training enables patients to identify and prioritize
ADL problems, barriers to performance, and strategies to resolve the barriers.7,8 Community
Participation Transition after Stroke (COMPASS) is a novel program that combines environmental
modifications and strategy training during the transition from IR to home to facilitate community
reintegration after stroke. If effective, this program will reduce disability in ADL performance and
improve participation outcomes.
The primary objective of this study is to compare the efficacy of COMPASS with an equivalent
dose of attentional control (AC; stroke education) for significant improvements in the primary
outcome (community participation) and secondary outcomes (ADL performance and a reduction in
environmental barriers in the home after stroke). Secondary objectives of this study include
evaluating alternative outcome measures of participation, function, patient-reported quality of life,
and caregiver burden that permit comparison with other stroke clinical trials and confirm the safety
of COMPASS and evaluating process outcomes such as reach, cost, fidelity, and adherence.

Methods
Study Design
The study is a phase 2b randomized clinical trial that includes 180 patients receiving IR. We will
compare COMPASS with an AC group for superiority. The Standard Protocol Items:
Recommendations for Interventional Trials (SPIRIT) reporting guideline was followed in developing
this protocol. The full trial protocol is available in the Supplement.

Study Setting and Population
This study takes place in the homes of participants living within 60 miles of the St Louis, Missouri,
metropolitan area. We are recruiting patients who have had an acute stroke, are 50 years or older,
were independent in ADL performance prior to stroke, plan to discharge to home, and are medically
stable. Our initial recruitment plan included only participants with ischemic stroke. We modified our
inclusion criteria to include participants with a diagnosis of hemorrhagic stroke based on
recommendations from reviewers and from physicians on the study team. We are excluding
survivors with terminal diseases that limit life expectancy to less than 6 months, previously
diagnosed cognitive disorders (eg, dementia) or cognitive impairment after stroke that makes
interpretation of the self-rated scales difficult (ie, Short Blessed Test9 score of ⱕ10), moderate to
severe aphasia (National Institutes of Health Stroke Scale10 Best Language rating of ⱖ2), or who
reside in a congregate living facility. We are also recruiting the primary informal caregivers of enrolled
participants. Caregivers must be 18 years or older and speak English to participate. Participant flow
is outlined in the Figure.

Recruitment and Consent
Participants are recruited near the time of transfer from acute care to IR and during IR. A study team
member visits all patients who meet the inclusion criteria and invites them to participate in the study.
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Written informed consent is obtained. Caregivers provide consent during 1 of 4 treatment or control
visits after the participant with stroke has returned home. All study procedures have been approved
by the institutional review board at Washington University in St Louis.

Randomization and Blinding
Participants are allocated into the education control group or the home modification intervention
group using a 1:1 ratio via randomization sequences generated a priori by the study statistician using
a computerized formal probability model. Functional status is a strong predictor of recovery.11
Therefore, randomization is balanced using the participant’s IR admission Functional Independence
Measure12 score. There are 3 allocation strata for Functional Independence Measure scores; each
strata corresponds with a level of functioning, ie, low, moderate, or high. Age is also a predictor of
stroke outcomes, so randomization is balanced on age as well. There are 5 allocation strata for age,
with each age block divided into 10-year increments, starting with age 50 years. There are a total of
15 strata, and we randomly allocate participants into 1 of 2 groups: treatment or control.
Randomization sequence concealment will be achieved by query of the Research Electronic Data
Capture (REDCap) system.13 After the baseline assessment (T1a), results are securely uploaded and
stratification variables (ie, Functional Independence Measure score and age) are entered and locked.

Figure. Flow Diagram of the Community Participation Transition After
Stroke (COMPASS) Trial
Initial referral from Barnes Hospital Stroke Patient
Access Core or the Rehabilitation Institute of
St Louis attending physicians

Medical record review for initial screening
Confirmed stroke diagnosis
No terminal diagnosis
Lives within 60 miles of hospital

Ineligible participants excluded

Participant approached for final screening
No significant cognitive impairment
No significant aphasia
Discharging home from inpatient rehabilitation

Ineligible participants excluded

Participant consent obtained and baseline home visit
scheduled to occur while participant still in inpatient
rehabilitation

Treatment arm
Four 75-minute in-home
occupational therapy visits

Control arm
Four 75-minute in-home
education sessions

Immediate postintervention
follow-up visit

Immediate postintervention
follow-up visit

Booster 1

Booster 1

Booster 2

Booster 2

6-month poststroke follow-up visit

6-month poststroke follow-up visit

12-month poststroke follow-up visit

12-month poststroke follow-up visit
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The interventionist completing the T1a elicits the treatment assignment in the field in real time using
a secure data connection to REDCap, allowing in-home treatment of the participants assigned to the
intervention group to begin immediately.
Inpatient rehabilitation staff from The Rehabilitation Institute of St Louis (TRISL) are blinded to
allocation so that they do not modify their inpatient or discharge treatment plans. Follow-up raters
are blind to allocation. To determine the effectiveness of our single-blinded protocol, we ask the
rehabilitation therapists to complete a brief assessment to determine whether group assignments
were revealed during evaluation. All incidents of unblinding are documented as protocol violations.

Intervention
Study Procedures
The COMPASS manual fully defines and justifies each element of the intervention. The treatment
includes 1 predischarge14,15 and four 75-minute postdischarge16 visits. The intervention is followed by
2 booster sessions.
Baseline Home Visit for All Participants With Stroke
Prior to randomization and discharge, an occupational therapy interventionist conducts a baseline
activity assessment in the home (T1a). We use the In-Home Occupational Performance Evaluation
(I-HOPE)17 to establish baseline activity patterns and identify environmental barriers in the home.
Telephone Assessment
Participation assessments (T1b) are conducted for both groups by telephone 2 days after discharge
from IR to allow time for participants to adjust and personally assess their community participation. A
blinded rater conducts the assessment for the primary, secondary, and exploratory end points.
Baseline Home Visit for Caregivers
If a caregiver is present, the occupational therapy interventionist or a trained graduate assistant
collects basic demographic information from the caregiver and asks questions regarding stress and
self-efficacy using the Perceived Stress Scale18 and Caregiver Inventory19 during 1 of 4 treatment or
control visits.
Intervention Group
The data from the I-HOPE, demographic assessments, and assessment of functional abilities are used
by the interventionist to develop an environmental modification intervention plan. Environmental
modifications addressing basic ADLs are installed prior to discharge if possible. On returning home,
the participant receives the remaining intervention visits, which focus on resumption of activities in
the home and community. Additional environmental supports are provided as needed, and the
occupational therapy interventionist and participant work together on poststroke community
reintegration by using strategy-training techniques. Problem areas addressed are participant specific
(ie, tailored), but all participants receive identical intervention components. The standardized
components include assessment, identification of problematic activities (and environmental
barriers), identification of solutions, implementation of solutions selected by the participant,
training, and active practice of daily activities in the home and community.
AC Treatment
The control group experiences the same effects of time and attention in the home but no effect on
the outcome of interest.20 A trained graduate assistant provides four 75-minute sessions. Topics
include stroke symptoms, risk factors and preventing stroke recurrence, nutrition, managing
emotions, sleep, fatigue, pain, social support, and sexuality. Environmental barriers are not
addressed in the educational sessions.
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Follow-up Period for All Participants
Participants with stroke and their caregivers are reassessed after intervention (T2) and at 6 and 12
months after stroke (T3 and T4). The follow-up activity, participation, and process assessments are
conducted in the home. Falls and health care utilization are collected monthly by telephone.

Data Collected
Assessments used to collect data for the primary, secondary, and exploratory outcomes are listed in
the Table.17-19,21-26 All measures are assessed at T1, T2, T3, and T4.

Statistical Analysis
Intention-to-Treat Analysis
We will perform our analyses using an intention-to-treat paradigm. It is not possible for participants
to switch conditions, as 2 groups of therapists are trained to provide either the intervention or
control visits and rehabilitation staff are blind to group allocation. We will exclude the data of any
individuals who drop out prior to randomization. We will perform exploratory data analysis looking
for extreme or otherwise unusual values. Nonnormally distributed and heteroscedastic data will be
transformed as necessary.

Table. Outcome Assessments and Variables
Variable

Measurea

Primary Outcome
Participation

RNLI,21 an 11-item questionnaire, quantifies participation
(basic self-care, functional mobility, avocational and
productive pursuits, and travel in the community)

Secondary Outcomes
Daily activity
performance

SIS ADL domain,22 a stroke-specific assessment of healthrelated quality of life, discriminates across 4 Rankin levels
of stroke severity (P ≤ .01)23 and demonstrated a moderate
(0.44) pre-post effect size between groups in our pilot
I-HOPE17 evaluates the performance of older adults in the
home, measuring limitations in daily activities, selfreported performance, and satisfaction with performance
of problematic activities

Barriers in the
environment

I-HOPE environment subscale17 measures the magnitude of
environmental barriers that influence performance

Exploratory End Points
Daily activity
performance

BI24 assesses the ability of an individual to care for him
or herself

Depression

GDS, short form,25 a 15-item screening tool, identifies
depression in older adults

Health-related
quality of life

PROMIS Physical and Mental Health Scales,26 a rigorously
tested measurement tool, measures patient-reported
outcomes that have a major impact on quality of life across
a variety of chronic diseases

Caregiver
burden and
stress

CGI19 is a valid and reliable measure, consisting of 4
subscales: managing medical information (3 items), caring
for the care recipient (7 items), caring for oneself (5 items),
and managing difficult interactions and emotions (6 items)
PSS,18 a stress assessment instrument, measures the degree
to which situations in an individual’s life are considered
stressful

Abbreviations: ADL, activities of daily living; BI, Barthel Index; CGI, Caregiver
Inventory; GDS, Geriatric Depression Scale; I-HOPE, In-Home Occupational
Therapy Performance Evaluation; PROMIS, Patient-Reported Outcome
Measurement Information System; PSS, Perceived Stress Scale; RNLI,
Reintegration Into Normal Living Index; SIS, Stroke Impact Scale.
a

All measures were collected at 4 points: baseline, immediately after
intervention, 6 months after stroke, and 12 months after stroke.
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Baseline Analyses
We will use unpaired t tests and χ2 tests to compare baseline characteristics in the 2 groups for
descriptive information. When statistical assumptions are not met, we may use Wilcoxon or Fisher
exact tests.
Missing Data
We expect missing values in the outcome measures because of dropout, death, missed assessment,
or nonresponse. Our main analysis, a linear mixed-effects model, accommodates missing values of
outcome variables under a missing-at-random assumption.27 Assuming that missing data occur at
random, inferences will be valid even if we have differential dropout by intervention arm. If the
missing data mechanism is not ignorable (ie, missing not at random), then mixed-effects selection
models or pattern-mixture models will be used.28

Primary Study Objectives
Primary Study Outcome Analysis
All data will be analyzed using SAS version 9.4 (SAS Institute). The primary analysis (testing primary
hypothesis) will be based on a linear mixed model using baseline and 12-month Reintegration to
Normal Living Index (RNLI)21 scores, accounting for the relationship between a participant’s repeated
measurements and time. The fixed-effect portion of the model will have the form Yit = β0 + β1 × 12
months + β2Group + β3Group × 12month, in which Yit is the RNLI score for participant i at baseline
(time 0) and 12 months (time 1), and Group indicates study arm. In this model, the baseline RNLI is
modeled as a dependent variable.27 For improved precision, the model will be adjusted for baseline
covariates including race, sex, depression, and length of hospital stay if an imbalance in covariates
between arms is observed in baseline analyses. In this model, β0 is the mean RNLI score for the
control arm at time 0, and β1 is the change in the mean RNLI from baseline to time 1 for the control
arm; β2 is the mean RNLI score for the treatment arm at time 0, and β3 is the change in mean RNLI
from time 0 to time 1 for the treatment arm. The primary hypothesis is that the difference in the
change in RNLI scores from time 0 to time 1 between arms will be tested by examining β3, which
estimates the difference.
Secondary Study Outcome Analysis
For secondary analyses of the change in Stroke Impact Scale (SIS)22 score and I-HOPE score at 12
months, we will use the same approach as for the primary analysis because these 2 outcomes are also
continuous. We have overall type I error control for testing the 12-month change in these 3 analyses
at the design stage. The significance level for testing is P < .016, and all tests will be 2-tailed. In
addition to comparing the 12-month change, we will extend the model by including scores
immediately after intervention and at 6 months to see whether the difference in outcomes is
achieved at those points. Depending on the form of the time variable in the model, we will use
appropriate regression coefficients or a linear combination of the regression coefficients to
determine the difference in change of these scores between arms at certain points. Interpretation of
these results should be cautious because we have not controlled for the type I error in these analyses.
Because it is possible that severity of functional impairment after stroke may affect response to
treatment, we will analyze impact of functional impairment on response to treatment. We will
examine functional impairment by group interaction to examine possible differential intervention
effects of functional impairment on community participation and performance of daily activities.

Secondary Study Objectives
Safety
To determine whether the intervention poses no greater risk than AC, we will examine the
differences in number of falls and rehospitalizations between groups. The statistical models for count
data will be used for analyses of these 2 outcomes. Using the number of falls as an example, we will
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fit a Poisson regression model (with overdispersion adjustment if necessary), in which a dummy
variable for the intervention arm is used. The regression parameter estimate for this dummy variable
is the log of rate ratio of falls for COMPASS intervention vs control arms, and the exponentiation of
the regression parameter estimate is the rate ratio. Using the parameter estimate and its standard
error, we can construct a 2-sided 95% CI for the rate ratio. We expect the confidence interval for rate
ratio will include 1, indicating no significant difference in the fall rate between the 2 groups.
Process Analysis and Economic Evaluation
Acceptability and feasibility will be evaluated to aid in the interpretability of the trial; COMPASS will
have high acceptability (80% retention), high fidelity by therapists (95% of elements and 90% of
dosage delivered), low safety risk (no increased rate of falls or health care use compared with the AC
group), and high adherence (80% of modifications in use) at 12 months. We will conduct betweengroup comparisons of process end points collected at each point (time to first fall, number of
injurious falls, health care utilization rate, dosage delivered, and adherence rate) using unpaired t
tests or χ2 tests. We will compare the characteristics of patients who complete the assigned
intervention with the characteristics of patients who do not for differences in stroke severity and
comorbidities. Descriptive statistics will be used for costs per participant and adherence.

Sample Size Calculation
The study is designed to have 80% power to reject 3 null hypotheses of equal mean changes in the
primary and secondary endpoints (RNLI, SIS, and I-HOPE) using a 2-sided, 2-sample, unequalvariance t test with overall type I error less than .05. Based on our preliminary study data,29 the 3
alternative mean (SD) changes in intervention and control populations are 15.3 (22.6) vs 1.3 (23.4),
respectively, for RNLI, 15.7 (16.1) vs 5.6 (9.1), respectively, for the SIS ADL domain, and 62.1 (26.1) vs
46.2 (18.8), respectively, for the I-HOPE. With a 1:1 allocation ratio, 130 patients (65 in each group) are
needed for the RNLI outcome, 84 are needed for the SIS outcome, and 100 are needed for I-HOPE
outcome. We will enroll 180 patients to account for a 30% attrition rate. This magnitude of betweengroup difference is considered clinically meaningful based on prior relevant literature and is
achievable based on our pilot study. The sample size calculation includes the correlation between
baseline and follow-up measures and is based on analysis of change scores, which is equivalent in
efficiency to the proposed analytic model. Based on the number of participants with stroke, we will
enroll an equivalent number of caregivers.

Safety Reporting
Because risk in the proposed study is considered minimal, the principal investigator is monitoring the
study for adverse events, serious adverse events, and adherence to the protocol. The principal
investigator will be responsible for reviewing study progress and outcomes including recruitment,
data quality, safety, and efficacy.

Adverse Events and Serious Adverse Events
All serious adverse events will be reported to the Washington University Human Research Protection
Office using the Electronic Serious Adverse Event Reporting System. Reports will adhere to the
following timeframes: (1) death, immediately; (2) life-threatening, within 7 calendar days; and (3) all
other serious adverse events, within 15 calendar days.

Handling and Storage of Data and Documents
Data are directly entered into a REDCap database, a secure, web-based application designed to
support data capture for research studies.13 The REDCap servers are securely housed in an on-site,
limited-access data center managed by the Division of Biostatistics at Washington University.
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Dissemination Policy
Study results will be submitted to peer-reviewed journals and presented at conferences on
occupational therapy, stroke, aging, and public health. After publication, study participants will be
informed of the results of the study.

Discussion
Most stroke survivors report the inability to perform ADLs, decreased quality of life, and reduced
community participation.23,30,31 Inpatient rehabilitation does not typically address the
environmental barriers stroke survivors face when returning to the community.29 As a result, patients
leave IR without the necessary skills to successfully return home. Emerging evidence, including our
pilot study,32 demonstrates that it is possible to intervene during the transition from IR to home using
compensatory approaches. However, it is unknown if an environmental modification intervention to
reduce excess disability and improve community participation in the stroke population is effective.
The findings of this phase 2b COMPASS trial will fill a critical gap in stroke rehabilitation evidence by
providing important information about the long-term participation and environmental barriers of
stroke survivors. If effective, this program will reduce disability in ADL performance and improve
participation outcomes. We anticipate findings will resolve significant unmet need among stroke
survivors with residual disability. At the conclusion of this study, we will understand the intervention’s
efficacy, acceptance, safety issues, and optimal end points.
There are significant strengths of this study. First, COMPASS is designed for rapid translation.
The intervention incorporates the elements of the Reach, Effectiveness, Adoption, Implementation,
and Maintenance dissemination framework. The intervention was designed to facilitate rapid uptake
in everyday practice, and it has standardized protocols for delivery with high fidelity. Second,
patients at TRISL are enthusiastic about participating. Patient satisfaction surveys at TRISL indicate
patient requests for home modifications and continued stroke education after discharge. Staff
therapists and attending physicians at TRISL are excited about the study and are eager to make
referrals to the study.

Limitations
There are potential limitations to this study. This is a single-site design, which reduces the
generalizability of the findings. Patients at TRISL are comparable nationally regarding length of stay
and treatment; however, our pilot sample had a higher percentage of African American participants
than in the general population of stroke survivors. It is also possible that baseline severity of disability
may affect the response to the intervention. It may be that those with the most severe functional
impairment derive the greatest benefit. Conversely, it is possible that the response to the
intervention will be blunted in more impaired participants. We will conduct subanalyses to explore if
a differential effect exists.

Conclusions
We designed this randomized clinical trial to investigate the efficacy and safety of a novel enhanced
rehabilitation transition program to reduce environmental barriers and improve daily activity
performance and community participation. This study targets individuals 50 years and older who
have experienced an acute stroke. Trial findings have the potential to provide evidence for the
efficacy and safety of a transition program designed to increase the independence of stroke
survivors. If this study finds that the novel enhanced rehabilitation transition program is successful,
future research could be extended to other IR sites and populations in a phase 3 trial.
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